Related Experiment Video
Updated: Jun 8, 2025

04:23
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
242
Association between phase angle and sarcopenia in patients with connective tissue diseases
Toshiyuki Moriyama1, Mizuki Tokunaga2, Ryoko Hori2
1Department of Rehabilitation Medicine, University of Occupational and Environmental Health, School of Medicine, Japan; National Hospital Organization Fukuokahigashi Medical Center, Japan.
Clinical Nutrition ESPEN
|November 1, 2024
Summary
Phase angle effectively detects sarcopenia in connective tissue disease (CTD) patients. New cutoff values aid early identification and management of sarcopenia in men and women with CTDs.
Area of Science:
- Gerontology
- Rheumatology
- Nutritional Science
Background:
- Sarcopenia detection and management are crucial for patients with connective tissue diseases (CTDs).
- The association between phase angle and sarcopenia in CTD patients remains uncharacterized.
- This study addresses the knowledge gap regarding phase angle as a biomarker for sarcopenia in CTDs.
Purpose of the Study:
- To investigate the relationship between phase angle and sarcopenia in patients with CTDs.
- To determine optimal phase angle cutoff values for early sarcopenia detection in CTD patients.
- To differentiate sarcopenia prevalence and phase angle associations by sex within the CTD cohort.
Main Methods:
- Retrospective cross-sectional study of 279 hospitalized CTD patients undergoing rehabilitation.
- Bioimpedance analysis utilized to measure phase angle.
- Sarcopenia assessed using the Asian Working Group for Sarcopenia criteria.
Main Results:
- Sarcopenia was prevalent in 134 (48%) of the CTD patients.
- Patients with sarcopenia exhibited significantly lower phase angle values compared to those without sarcopenia.
- Multivariate analysis confirmed phase angle's significant association with sarcopenia, independent of confounders, with optimal cutoffs of 4.6° for men and 4.3° for women.
Conclusions:
- Phase angle serves as a valuable and accessible marker for sarcopenia in CTD populations.
- Established phase angle cutoff values (4.6° for men, 4.3° for women) can guide early sarcopenia detection.
- These findings support the integration of phase angle measurements into routine clinical practice for improved CTD patient management.

